Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Heerspink, HJL; Sjostrom, CD; Jongs, N; Chertow, GM; Kosiborod, M; Hou, FF; McMurray, JJV; Rossing, P; Correa-Rotter, R; Kurlyandskaya, R; Stefansson, BV; Toto, RD; Langkilde, AM; Wheeler, DC

Heerspink, HJL (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, POB 30 001, NL-9700 RB Groningen, Netherlands.; Heerspink, HJL (corresponding author), George Inst Global Hlth, Level 5,1 King St, Sydney, NSW 2042, Australia.

EUROPEAN HEART JOURNAL, 2021; 42 (13): 1216

Abstract

Aims Mortality rates from chronic kidney disease (CKD) have increased in the last decade. In this pre-specified analysis of the DAPA-CKD trial, we det......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索